Skip to content
healthcare.dev

BM BM184 DROPS

NDC 85816-2184, Benzoic acid, Buchu, Belladonna, Terebinthina, Thlapsi b.p, Triticum rep, liquid, from BM Private Limited.

Product NDC
85816-2184
Status
Listed
Labeler
BM Private Limited
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/85816-2184 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AGATHOSMA BETULINA LEAF1 [hp_X]/mL
  • ATROPA BELLADONNA10 [hp_X]/mL
  • BENZOIC ACID10 [hp_X]/mL
  • CAPSELLA BURSA-PASTORIS WHOLE1 [hp_X]/mL
  • TURPENTINE OIL1 [hp_X]/mL
  • ELYMUS REPENS ROOT1 [hp_X]/mL

Pharmacologic classes

Ammonium Ion Binding Activity [MoA]; Nitrogen Binding Agent [EPC]

Package NDCNDC-11Package
85816-2184-18581621840130 mL in 1 BOTTLE, GLASS (85816-2184-1)
85816-2184-285816218402500 mL in 1 JAR (85816-2184-2)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 85816-2184 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/85816-2184 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 85816-2184. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.